Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
24 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014', provides an overview of the Paras Biopharmaceuticals Finland Oy's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Paras Biopharmaceuticals Finland Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Paras Biopharmaceuticals Finland Oy including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Paras Biopharmaceuticals Finland Oy's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Paras Biopharmaceuticals Finland Oy's pipeline products Reasons to buy - Evaluate Paras Biopharmaceuticals Finland Oy's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Paras Biopharmaceuticals Finland Oy in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Paras Biopharmaceuticals Finland Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Paras Biopharmaceuticals Finland Oy and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Paras Biopharmaceuticals Finland Oy - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Paras Biopharmaceuticals Finland Oy and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Paras Biopharmaceuticals Finland Oy Snapshot 4 Paras Biopharmaceuticals Finland Oy Overview 4 Key Information 4 Key Facts 4 Paras Biopharmaceuticals Finland Oy - Research and Development Overview 5 Key Therapeutic Areas 5 Paras Biopharmaceuticals Finland Oy - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Paras Biopharmaceuticals Finland Oy - Pipeline Products Glance 9 Paras Biopharmaceuticals Finland Oy - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Paras Biopharmaceuticals Finland Oy - Drug Profiles 10 anakinra biosimilar 10 Product Description 10 Mechanism of Action 10 R&D Progress 10 PB-3010 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 PB-3020 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 PB-3030 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 PB-3040 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 PB-4020 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 PPB-4010 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 teriparatide biosimilar 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Paras Biopharmaceuticals Finland Oy - Pipeline Analysis 18 Paras Biopharmaceuticals Finland Oy - Pipeline Products by Target 18 Paras Biopharmaceuticals Finland Oy - Pipeline Products by Route of Administration 19 Paras Biopharmaceuticals Finland Oy - Pipeline Products by Molecule Type 20 Paras Biopharmaceuticals Finland Oy - Pipeline Products by Mechanism of Action 21 Paras Biopharmaceuticals Finland Oy - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24
List of Tables Paras Biopharmaceuticals Finland Oy, Key Information 4 Paras Biopharmaceuticals Finland Oy, Key Facts 4 Paras Biopharmaceuticals Finland Oy - Pipeline by Indication, 2014 6 Paras Biopharmaceuticals Finland Oy - Pipeline by Stage of Development, 2014 7 Paras Biopharmaceuticals Finland Oy - Monotherapy Products in Pipeline, 2014 8 Paras Biopharmaceuticals Finland Oy - Preclinical, 2014 9 Paras Biopharmaceuticals Finland Oy - Pipeline by Target, 2014 18 Paras Biopharmaceuticals Finland Oy - Pipeline by Route of Administration, 2014 19 Paras Biopharmaceuticals Finland Oy - Pipeline by Molecule Type, 2014 20 Paras Biopharmaceuticals Finland Oy - Pipeline Products by Mechanism of Action, 2014 21
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.